Assessment considerations include: Serum B12 measurement may be considered before initiating Ozempic in high-risk patients (those on metformin, older adults, those with gastrointestinal symptoms, or with restricted diets) Testing for B12 deficiency should be performed in patients on metformin who develop symptoms suggestive of deficiency, as advised by the MHRA Drug Safety Update Consider periodic monitoring in patients with risk factors for B12 deficiency, rather than routine annual testing for all patients Full blood count to identify macrocytic anaemia, which may indicate B12 or folate deficiency Clinical assessment for symptoms of deficiency: fatigue, paraesthesia, cognitive changes, glossitis, or balance problems If B12 levels are borderline or if clinical suspicion remains despite normal serum B12 (measured in pmol/L, with laboratory-specific reference ranges), additional testing may be considered according to local laboratory protocols
People have filed Ozempic lawsuits after they suffered gastroparesis (paralyzed stomach), excessive vomiting, intestinal blockages and ileus
For licensing or partnership opportunities within Adalvos diabetes portfolio, contact the team today.
Take, for example, Martina Big's story
Im now on Metformin and Ozempic, down under 22% body fat and down 25kg, 23kg or so of which is fat
